Related Experiment Videos
Cannabinoid receptors as therapeutic targets
1Department of Anesthesiology and Physiology, University of Washington School of Medicine, Seattle, WA 98195-6540, USA. kmackie@u.washington.edu
Annual Review of Pharmacology and Toxicology
|January 13, 2006
Summary
The endocannabinoid system, targeting CB1 and CB2 receptors, influences key bodily functions. Research suggests therapies affecting this system hold clinical promise for various conditions.
Area of Science:
- Neuroscience
- Pharmacology
- Physiology
Background:
- Endocannabinoid system involves CB1 and CB2 cannabinoid receptors, crucial for metabolic regulation, pain, anxiety, and immune function.
- These G protein-coupled receptors are modulated by endogenous cannabinoids (endocannabinoids).
Purpose of the Study:
- To review the components of the endocannabinoid system.
- To discuss promising endocannabinoid-based therapies.
Main Methods:
- Literature review of preclinical studies.
- Analysis of therapeutic strategies targeting cannabinoid receptors directly or indirectly.
Main Results:
- Cannabinoid receptors are key targets for therapeutic intervention.
- Modulating endocannabinoid metabolism offers an indirect therapeutic approach.
- Preclinical evidence supports the clinical utility of influencing the endocannabinoid system.
Conclusions:
- The endocannabinoid system presents a significant target for novel therapeutic development.
- Further research into endocannabinoid-based therapies may yield clinical benefits for various physiological and pathological processes.